Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of the National Cancer Institute

• Publication date

  1999-06-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/91.11.961PMID 10359549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer in Australian women under the age of 40

  1998cited by this paper
• Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty.

  1998cited by this paper
• Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.

  1997cited by this paper
• Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

  1997cited by this paper
• Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.

  1997cited by this paper
• Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer

  1997cited by this paper
• Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.

  1997cited by this paper
• The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

  1997cited by this paper
• Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.

  1996cited by this paper
• Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy).

  1995cited by this paper
• The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

  1995cited by this paper
• The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

  1994cited by this paper
• Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

  1993cited by this paper
• Male breast cancer and the androgen receptor gene

  1993cited by this paper
• A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

  1992cited by this paper
• Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale.

  1992cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• The contribution of inherited predisposition to cancer incidence.

  1990cited by this paper

• Molecular genetic features of hereditary forms of breast cancer (systematic review)

  2023cites this paper
• Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden

  2023cites this paper
• Androgen Receptors in the Pathology of Disease

  2021cites this paper
• Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

  2019cites this paper
• MHC/HLA Class I Loss in Cancer Cells.

  2019cites this paper
• Étude de la relation entre la longueur du triplet CAG du gène AR (récepteur à l’androgène) et du cancer du sein chez la femme Algérienne

  2019cites this paper
• Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.

  2018cites this paper
• Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms

  2017cites this paper
• Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study.

  2015cites this paper
• Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population.

  2015cites this paper
• CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies

  2015cites this paper
• Genetic analysis of Mild Androgen Insensitivity Syndrome (MAIS) and breast cancer in a South African Indian family

  2015cites this paper
• Молекулярно-генетические особенности мезотелиомы брюшины

  2014cites this paper
• Androgen receptor genetic variants in male patients with ankylosing spondylitis in Taiwan

  2013cites this paper
• Microsatellites in the Estrogen Receptor (ESR1, ESR2) and Androgen Receptor (AR) Genes and Breast Cancer Risk in African American and Nigerian Women

  2012cites this paper
• Androgen Receptor Gene CAG Repeat Polymorphism and Breast Cancer Risk in Iranian Women: A Case‐Control Study

  2011cites this paper
• CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world

  2011cites this paper
• Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.

  2011cites this paper
• A MIS PADRES

  2010cites this paper
• Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women

  2010cites this paper
• Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy

  2010cites this paper
• Association between androgen receptor gene CAG repeat polymorphism and breast cancer risk: a meta-analysis

  2010influential citation
• A BRCA1 promoter variant (rs11655505) and breast cancer risk

  2010cites this paper
• BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

  2009cites this paper
• Insights from AR Gene Mutations

  2009cites this paper
• Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility

  2008cites this paper
• Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.

  2008cites this paper
• Androgens and androgen receptors in breast cancer.

  2007cites this paper
• Associations between Androgen and Vitamin D Receptor Microsatellites and Postmenopausal Breast Cancer

  2007cites this paper
• Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.

  2007cites this paper
• Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis

  2007cites this paper
• Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

  2007cites this paper
• Phenotypic heterogeneity of mutations in androgen receptor gene.

  2007cites this paper
• Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.

  2007cites this paper
• Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.

  2007cites this paper
• Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer

  2006cites this paper
• Androgen receptor mediated activity in the ovary : implications for Polycystic Ovary Syndrome

  2006cites this paper
• Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium

  2006cites this paper
• CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer

  2005cites this paper
• Androgen Receptor and Prostate-Specific Antigen Gene Polymorphisms and Breast Cancer in African-American Women

  2005cites this paper
• Microsatellite profile in hormonal receptor genes associated with breast cancer

  2005cites this paper
• Prevention of hormone-related cancers: breast cancer.

  2005cites this paper
• Structural and functional consequences of glutamine tract variation in the androgen receptor.

  2004cites this paper
• Genetic Predisposition to Male and Female Breast Cancer

  2004cites this paper
• Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy

  2004cites this paper
• The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2004cites this paper
• DDH181 1677..1692

  2004cites this paper
• Increased frequency of long androgen receptor CAG repeats in male breast cancers

  2004cites this paper
• Androgen Receptor Gene Alterations in Finnish Male Breast Cancer

  2004cites this paper
• Advances in Brief Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy 1

  2004cites this paper
• Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer

  2004cites this paper
• Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.

  2003cites this paper
• Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene

  2003cites this paper
• The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer

  2003cites this paper
• Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

  2003influential citation
• Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors

  2003cites this paper
• Androgen receptor status in female breast cancer: RT-PCR and Western blot studies

  2002cites this paper
• Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.

  2002cites this paper
• Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

  2002cites this paper
• Androgen receptor CAG repeats and prostate cancer.

  2002cites this paper
• The androgen receptor CAG repeat: a modifier of carcinogenesis?

  2002cites this paper
• Androgens and mammary growth and neoplasia.

  2002cites this paper
• Modifiers of risk of hereditary breast and ovarian cancer

  2002cites this paper
• Androgens and Androgen Receptor

  2002cites this paper
• Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

  2002cites this paper
• The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

  2002cites this paper
• The Expanded Poly-Q Length Within AR and AR Coregulator AIB1 and Their Clinical Implications

  2002cites this paper
• HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW Androgen Receptor CAG Repeats and Prostate Cancer

  2002cites this paper
• High frequency of skewed X inactivation in young breast cancer patients

  2002cites this paper
• The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome.

  2002cites this paper
• ESTROGENS , ANDROGENS , AND BREAST DEVELOPMENT

  2002cites this paper
• Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

  2002cites this paper
• The polymorphic CAG repeat of the androgen receptor gene: a potential role in breast cancer in women over 40

  2001cites this paper
• The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma

  2001cites this paper
• The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.

  2001cites this paper
• Modification of BRCA 1-and BRCA 2-associated Breast Cancer Risk by AIB 1 Genotype and Reproductive History 1

  2001cites this paper
• CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

  2001influential citation
• Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.

  2001cites this paper
• Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

  2001cites this paper
• Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

  2001cites this paper
• Characterization of BRCA1 Protein Product

  2000cites this paper
• Polymorphic repeat in AIB1 does not alter breast cancer risk

  2000cites this paper
• Active allele loss of the androgen receptor gene contributes to loss of androgen receptor expression in female breast cancers.

  2000cites this paper
• Androgen receptor exon 1 cag repeat length and risk of ovarian cancer

  2000cites this paper
• The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer.

  2000cites this paper
• Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS).

  1999cites this paper
• No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.

  1999cites this paper